Literature DB >> 15385509

A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.

Ronald K Taylor1, Thomas J Kirn, Michael D Meeks, Terri K Wade, William F Wade.   

Abstract

Vibrio cholerae is a gram-negative bacterium that has been associated with cholera pandemics since the early 1800s. Whole-cell, killed, and live-attenuated oral cholera vaccines are in use. We and others have focused on the development of a subunit cholera vaccine that features standardized epitopes from various V. cholerae macromolecules that are known to induce protective antibody responses. TcpA protein is assembled into toxin-coregulated pilus (TCP), a type IVb pilus required for V. cholerae colonization, and thus is a strong candidate for a cholera subunit vaccine. Polypeptides (24 to 26 amino acids) in TcpA that can induce protective antibody responses have been reported, but further characterization of their amino acid targets relative to tertiary or quaternary TCP structures has not been done. We report a refinement of the TcpA sequences that can induce protective antibody. One sequence, TcpA 15 (residues 170 to 183), induces antibodies that bind linear TcpA in a Western blot as well as weakly bind soluble TcpA in solution. These antibodies bind assembled pili at high density and provide 80 to 100% protection in the infant mouse protection assay. This is in sharp contrast to other anti-TcpA peptide sera (TcpA 11, TcpA 13, and TcpA 17) that bind very strongly in Western blot and solution assays yet do not provide protection or effectively bind TCP, as evidenced by immunoelectron microscopy. The sequences of TcpA 15 that induce protective antibody were localized on a model of assembled TCP. These sequences are centered on a site that is predicted to be important for TCP structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385509      PMCID: PMC517590          DOI: 10.1128/IAI.72.10.6050-6060.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection.

Authors:  S H Lee; D L Hava; M K Waldor; A Camilli
Journal:  Cell       Date:  1999-12-10       Impact factor: 41.582

2.  Experimental cholera in infant mice: protective effects of antibody.

Authors:  W Chaicumpa; D Rowley
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

3.  A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria.

Authors:  D K Karaolis; S Somara; D R Maneval; J A Johnson; J B Kaper
Journal:  Nature       Date:  1999-05-27       Impact factor: 49.962

4.  Immune response genes modulate serologic responses to Vibrio cholerae TcpA pilin peptides.

Authors:  M D Meeks; T K Wade; R K Taylor; W F Wade
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

Authors:  R K Taylor; V L Miller; D B Furlong; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin.

Authors:  Lisa Craig; Ronald K Taylor; Michael E Pique; Brian D Adair; Andrew S Arvai; Mona Singh; Sarah J Lloyd; David S Shin; Elizabeth D Getzoff; Mark Yeager; Katrina T Forest; John A Tainer
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

7.  Evolutionary and functional analyses of variants of the toxin-coregulated pilus protein TcpA from toxigenic Vibrio cholerae non-O1/non-O139 serogroup isolates.

Authors:  E Fidelma Boyd; Matthew K Waldor
Journal:  Microbiology       Date:  2002-06       Impact factor: 2.777

8.  Secretion of a soluble colonization factor by the TCP type 4 pilus biogenesis pathway in Vibrio cholerae.

Authors:  Thomas J Kirn; Niranjan Bose; Ronald K Taylor
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

9.  Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

Authors:  D A Herrington; R H Hall; G Losonsky; J J Mekalanos; R K Taylor; M M Levine
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

10.  Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae.

Authors:  Long Hang; Manohar John; Muhammad Asaduzzaman; Emily Anna Bridges; Cecily Vanderspurt; Thomas J Kirn; Ronald K Taylor; Jeffrey D Hillman; Ann Progulske-Fox; Martin Handfield; Edward T Ryan; Stephen B Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 12.779

View more
  8 in total

1.  FppA, a novel Pseudomonas aeruginosa prepilin peptidase involved in assembly of type IVb pili.

Authors:  Sophie de Bentzmann; Marianne Aurouze; Geneviève Ball; Alain Filloux
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

2.  Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.

Authors:  Danielle E Baranova; Graham G Willsey; Kara J Levinson; Carol Smith; Joseph Wade; Nicholas J Mantis
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

3.  Characterization of two outer membrane proteins, FlgO and FlgP, that influence vibrio cholerae motility.

Authors:  Raquel M Martinez; Madushini N Dharmasena; Thomas J Kirn; Ronald K Taylor
Journal:  J Bacteriol       Date:  2009-07-10       Impact factor: 3.490

4.  Conserved regions from Neisseria gonorrhoeae pilin are immunosilent and not immunosuppressive.

Authors:  Johanna K Hansen; Karen P Demick; John M Mansfield; Katrina T Forest
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

5.  Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.

Authors:  Deborah R Leitner; Sandra Feichter; Kristina Schild-Prüfert; Gerald N Rechberger; Joachim Reidl; Stefan Schild
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

6.  Recombinant toxin-coregulated pilus A (TcpA) as a candidate subunit cholera vaccine.

Authors:  Somayeh Kiaie; Hamid Abtahi; Ghasem Mosayebi; MohammadYosef Alikhani; Iraj Pakzad
Journal:  Iran J Microbiol       Date:  2014-04

7.  Cholera Toxin Production in Vibrio cholerae O1 El Tor Biotype Strains in Single-Phase Culture.

Authors:  Yeongjun Baek; Donghyun Lee; Jiwon Lee; Youngbae Yoon; G Balakrish Nair; Dong Wook Kim; Eun Jin Kim
Journal:  Front Microbiol       Date:  2020-05-05       Impact factor: 5.640

8.  Replication of Vibrio cholerae classical CTX phage.

Authors:  Eun Jin Kim; Hyun Jin Yu; Je Hee Lee; Jae-Ouk Kim; Seung Hyun Han; Cheol-Heui Yun; Jongsik Chun; G Balakrish Nair; Dong Wook Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-14       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.